Impact of universal two-dose vaccination on varicella epidemiology in Navarre, Spain, 2006 to 2012

Eurosurveillance

Volumn 18, Issue 32, 2013, Pages

  Garcia Cenoz M ^a,b   Castilla, J ^a,b   Chamorro, J ^c   Martinez Baz I ^a,b   Martinez Artola V ^c   Irisarri, F ^a,b   Arriazu, M ^a,b   Ezpeleta, C ^c   Barricarte, A ^a,b  

^a INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Universidad Pública de Navarra   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; ARTICLE; CHICKENPOX; CHILD; DISEASE CLASSIFICATION; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; REGISTER; SEASONAL VARIATION; SPAIN; VACCINATION;

EID: 84881486540     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2013.18.32.20552     Document Type: Article

References (42)

1. Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1365-76. http://dx.doi.org/10.1016/S0140-6736(06)69561-5
2. Varicella vaccines. WHO position paper. Wkly Epidemiol Rec. 1998;73(32):241-8. PMid:9715106
3. Arnedo-Pena A, Puig-Barbera J, Aznar-Orenga MA, Ballester-Albiol M, Pardo-Serrano F, Bellido-Blasco JB, et al. Varicella vaccine effectiveness during an outbreak in a partially vaccinated population in Spain. Pediatr Infect Dis J. 2006;25(9):774-8. http://dx.doi.org/10.1097/01.inf.0000232631.06763.8b PMid:16940832
4. Marin M, Guris D, Chaves SS, Schmid S, Seward JF, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-4):1-40. PMid:17585291
5. Ross AH. Modification of chicken pox in family contacts by administration of gamma globulin. N Engl J Med. 1962;267:369-76. http://dx.doi.org/10.1056/NEJM196208232670801 PMid:14494142
6. Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA. 2002;287(5):606-11. http://dx.doi.org/10.1001/jama.287.5.606 PMid:11829699
7. Grose C. Varicella vaccination of children in the United States: Assessment after the first decade 1995-2005. J Clinical Virol. 2005;33(2):89-95. http://dx.doi.org/10.1016/j.jcv.2005.02.003 PMid:15911422
8. Seward JF, Marin M, Vazquez M. Varicella vaccine effectiveness in the US vaccination program: A review. J Infect Dis. 2008;197(Suppl 2):S82-9. http://dx.doi.org/10.1086/522145 PMid:18419415
9. Macartney KK, Beutels P, McIntyre P, Burgess MA. Varicella vaccination in Australia. J Paediatr Child Health. 2005;41(11):544-52. http://dx.doi.org/10.1111/j.1440-1754.2005.00717.x PMid:16398834
10. Carville KS, Riddell MA, Kelly HA. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia. Vaccine. 2010;28(13):2532-8. http://dx.doi.org/10.1016/j.vaccine.2010.01.036 PMid:20117265
11. Siedler A, Arndt U. Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveill. 2010;15(13):pii=19530. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19530
12. Pozza F, Piovesan C, Russo F, Bella A, Pezzotti P, Emberti Gialloreti L. Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy. Vaccine. 2011;29(51):9480-7. http://dx.doi.org/10.1016/j.vaccine.2011.10.022 PMid:22015389
13. Vazquez M, LaRussa PS, Gershon AA, Niccolai LM, Muehlenbein CE, Steinberg SP, et al. Effectiveness over time of varicella vaccine. JAMA. 2004;291(7):851-5. http://dx.doi.org/10.1001/jama.291.7.851 PMid:14970064
14. Kattan JA, Sosa LE, Bohnwagner HD, Hadler JL. Impact of 2-dose vaccination on varicella epidemiology: Connecticut-2005-2008. J Infect Dis. 2011;203(4):509-12. http://dx.doi.org/10.1093/infdis/jiq081 PMid:21199882 PMCid:PMC3071238
15. Fox J, Elveback L, Scott W, Gatewood L, Ackerman E. Herd immunity: basic concept end relevance to public health immunization practices. Am J Epidemiol. 1971;94(3):179-89. PMid:5093648
16. Fox J. Herd immunity and measles. Rev Infect Dis. 1983;5(3):463-6. http://dx.doi.org/10.1093/clinids/5.3.463 PMid:6879000
17. Orden Foral 19/2008, de 15 de febrero, de la Consejería de Salud, por la que se modifican las enfermedades incluidas en el Sistema de Vigilancia Epidemiológica de Navarra. [Local Order 19/2008, of 15 February, of the Ministry of Health, amending the diseases included in the Epidemiological Surveillance System of Navarra]. Boletín Oficial de Navarra. 2008:28. Spanish. Available from: http://sid.usal.es/leyes/discapacidad/12504/3-2-3/orden-foral-19-2008-de-15-de-febrero-de-la-consejera-de-salud-por-la-que-se-modifican-las-enfermedades-incluidas-en-el-sistema-de-vigilancia-epidemiol.aspx
18. Wonca International Classification Committee (WICC). International Classification of Primary Care-2nd Edition (ICPC-2). Bangkok: World Organization of Family Doctors (Wonca). [Accessed 10 Oct 2012]. Available from:http://www.rivm.nl/who-fic/cdromthesaurus/Pagerenglish.pdf
19. a Revisión Modificación Clínica. [International Classification of Diseases, 9th Revision Clinical Modification]. 8th ed. Madrid: Ministerio de Sanidad, Política Social e Igualdad, Secretaría General Técnica; 2012. Available fromhttp://www.msc.es/estadEstudios/estadisticas/docs/CIE9MC_8ed.pdf
20. Schmid DS, Jumaan AO. Impact of varicella vaccine on Varicella-Zoster Virus dynamics. Clin Microbiol Rev. 2010;23(1):202-17. http://dx.doi.org/10.1128/CMR.00031-09 PMid:20065330 PMCid:PMC2806663
21. National Statistics Institute (NSI). Population figures by Municipalities, Islands, Provinces and Autonomous Communities Madrid: NSI. [Accessed 18 Dec 2012]. Available from: http://www.ine.es/jaxi/menu.do?type=pcaxis&path=%2Ft20%2Fe260&file=inebase&L=1
22. Farrington CP. Estimation of Vaccine Effectiveness using the screening method. Int J Epidemiol. 1993;22(4):742-6. http://dx.doi.org/10.1093/ije/22.4.742 PMid:8225751
23. Mullooly JP, Maher JE, Drew L, Schuler R, Hu W. Evaluation of the impact of an HMO's varicella vaccination program on incidence of varicella. Vaccine. 2004;22(11-12):1480-5. http://dx.doi.org/10.1016/j.vaccine.2003.10.021 PMid:15063572
24. Kupek E, Tritany EF. Impact of vaccination against varicella on the reduction of the disease incidence in children and adolescents from Florianopolis, Brazil. J Pediatr (Rio J). 2009;85(4):365-8. http://dx.doi.org/10.1590/S0021-75572009000400016
25. Shapiro ED, Vazquez M, Esposito D, Holabird N, Steinberg SP, Dziura J, et al. Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis. 2011;203(3):312-5. http://dx.doi.org/10.1093/infdis/jiq052 PMid:21208922 PMCid:PMC3071110
26. Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA. 2005;294(7):797-802. http://dx.doi.org/10.1001/jama.294.7.797 PMid:16106004
27. Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics. 2004;114(3):786-92. http://dx.doi.org/10.1542/peds.2004-0012 PMid:15342855
28. Kwong JC, Tanuseputro P, Zagorski B, Moineddin R, Chan KJ. Impact of varicella vaccination on health care outcomes in Ontario, Canada: Effect of a publicly funded program? Vaccine. 2008;26(47):6006-12. http://dx.doi.org/10.1016/j.vaccine.2008.08.016 PMid:18761386
29. Banovic T, Yanilla M, Simmons R, Robertson I, Schroder WA, Raffelt NC, et al. Disseminated varicella infection caused by varicella vaccine strain in a child with low invariant natural killer T cells and diminished CD1d expression. J Infect Dis. 2011;204(12):1893-901. http://dx.doi.org/10.1093/infdis/jir660 PMid:22043019
30. Bernstein HH, Rothstein EP, Watson BM, Reisinger KS, Blatter MM, Wellman CO, et al. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics. 1993;92(6):833-7. PMid:8233746
31. Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes. Vaccine. 2000;18(25):2775-8. http://dx.doi.org/10.1016/S0264-410X(00)00100-6
32. Gao Z, Gidding HF, Wood JG, MacIntyre CR. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia. Epidemiol Infect. 2010;138(4):457-68. http://dx.doi.org/10.1017/S0950268809990860 PMid:19781116
33. Nguyen MD, Perella D, Watson B, Marin M, Renwick M, Spain CV. Incremental effectiveness of second dose varicella vaccination for outbreak control at an elementary school in Philadelphia, Pennsylvania, 2006. Pediatr Infect Dis J. 2010;29(8):685-9. http://dx.doi.org/10.1097/INF.0b013e3181d9f657 PMid:20354463
34. Brisson M, Melkonyan G, Drolet M, De Serres G, Thibeault R, De Wals P. Modeling the impact of one-and two-dose varicella vaccination on the epidemiology of varicella and zoster. Vaccine. 2010;28(19):3385-97. http://dx.doi.org/10.1016/j.vaccine.2010.02.079 PMid:20199763
35. Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J. 2004;23(2):132-7. http://dx.doi.org/10.1097/01.inf.0000109287.97518.67 PMid:14872179
36. Hope-Simpson RE. The Nature of Herpes Zoster: a Long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9-20. PMid:14267505 PMCid:PMC1898279
37. Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002;20(19-20):2500-7. http://dx.doi.org/10.1016/S0264-410X(02)00180-9
38. Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet. 2002;360(9334):678-82. http://dx.doi.org/10.1016/S0140-6736(02)09837-9
39. Brisson M, Edmunds WJ, Gay NJ. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol. 2003;70 Suppl 1(1):S31-7.
40. Tanuseputro P, Zagorski B, Chan KJ, Kwong JC. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program. Vaccine. 2011;29(47):8580-4. http://dx.doi.org/10.1016/j.vaccine.2011.09.024 PMid:21939721
41. Gaillat J, Gajdos V, Launay O, Malvy D, Demoures B, Lewden L, et al. Does monastic life predispose to the risk of Saint Anthony's fire (herpes zoster)? Clin Infect Dis. 2011;53(5):405-10. http://dx.doi.org/10.1093/cid/cir436 PMid:21844022
42. Plotkin SA, Starr SE, Connor K, Morton D. Zoster in normal children after varicella vaccine. J Infect Dis. 1989;159(5):1000-1. http://dx.doi.org/10.1093/infdis/159.5.1000 PMid:2540244